Tech Center 1600 • Art Units: 1641 1677 1678
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18959243 | ANALYZING CELL SAMPLES | Non-Final OA | Singular Genomics Systems, Inc. |
| 17889025 | DE-CROSSLINKING COMPOUNDS AND METHODS OF USE FOR SPATIAL ANALYSIS | Final Rejection | 10x Genomics, Inc. |
| 17781202 | LUMINESCENT ZWITTERIONIC POLYMERIC NANOPARTICLES | Final Rejection | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE |
| 18130874 | SELF-HEALABLE CHEMICAL DETECTING SENSOR EMBEDDING TRANSITION METAL-ADSORBED PAA-PVA-BORAX FIBER-GEL | Non-Final OA | UIF (University Industry Foundation), Yonsei University |
| 17934700 | METHODS FOR ENVIRONMENTAL CHITIN QUANTIFICATION | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 17931016 | METHODS FOR ANALYSIS OF TARGET MOLECULES IN BIOLOGICAL FLUIDS | Non-Final OA | GRAIL, LLC |
| 18317288 | CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION | Final Rejection | University of Washington through its Center for Commercialization |
| 17788779 | Methods for Reducing Nonspecific Interactions on Biological Samples | Non-Final OA | Ultivue, Inc. |
| 18251279 | IMPROVED ASSAYS TO DETECT NUCLEOSOME MODIFICATIONS USING ANTIBODY-TARGETED ENZYME DIGESTION | Non-Final OA | EPICYPHER, INC. |
| 17199228 | SAMPLE DEPLETION AND ENRICHMENT TO IMPROVE THE QUALITY OF DIAGNOSTIC TEST RESULTS | Final Rejection | VERAVAS, INC. |
| 17998559 | DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES THEREOF | Final Rejection | HUNILIFE BIOTECHNOLOGY, INC. |
| 17923262 | CELLULAR MATERIAL DETECTION PROBES | Non-Final OA | FLUORETIQ LIMITED |
| 17965761 | FREEZE-DRIED PREPARATION OF CHEMILUMINESCENT IMMUNE MICROSPHERES, AND PREPARATION METHOD AND APPLICATION THEREOF | Non-Final OA | Anbio (Xiamen) Biotechnology Co., Ltd |
| 17933460 | PHOTOREACTIVE AND CLEAVABLE PROBES FOR TAGGING BIOMOLECULES | Non-Final OA | Syncell (Taiwan) Inc. |
| 17802852 | NANOPARTICLES FOR SENSING USE AND PRODUCTION METHOD FOR SAME | Non-Final OA | TearExo Inc. |
| 17316665 | NANODIAMOND PARTICLES AND RELATED DEVICES AND METHODS | Final Rejection | Debina Diagnostics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy